Does FDA Approval Mean Anything? (w/Examples) + FAQs

Yes, FDA approval means the agency reviewed scientific evidence and determined a product’s benefits outweigh its known risks for the intended use. But “FDA approval” is not a guarantee of absolute safety. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires FDA to evaluate safety and effectiveness before high-risk products reach consumers. However, approximately 35 drugs have been recalled from the U.S. market since the 1970s—some after causing thousands of injuries or deaths.

In 2025 alone, the FDA’s Center for Drug Evaluation and Research (CDER) approved 46 novel drugs—yet many consumers mistakenly believe all products they buy are FDA-approved.

In This Article, You Will Learn:

🔍 The critical difference between FDA “approved,” “cleared,” “granted,” “registered,” and “authorized”—and why confusing them can cost you

💊 Which everyday products (supplements, cosmetics, CBD, pet food) are not FDA-approved and what that means for your safety

⚠️ Real examples of FDA-approved drugs and devices that were later recalled after causing serious harm or death

⚖️ How FDA approval affects your right to sue if you’re injured by a product

🛡️ How to protect yourself when FDA approval doesn’t guarantee safety

What Does “FDA Approval” Actually Mean?

The phrase “FDA approved” has a specific legal definition under 21 U.S.C. § 360e. When the FDA approves a product, the agency has determined that scientific data demonstrates the product’s benefits outweigh its known risks for the intended use. This designation applies only to:

• Prescription drugs
• Over-the-counter (OTC) drugs
• Biologics and vaccines
• Class III (high-risk) medical devices

For drugs, manufacturers must submit a New Drug Application (NDA) containing results from clinical trials demonstrating safety and efficacy. The FDA receives between 1,500 and 2,000 Investigational New Drug applications each year.

For Class III medical devices—products like pacemakers, heart valves, and breast implants—the Premarket Approval (PMA) process requires comprehensive clinical data, manufacturing quality compliance, and risk-benefit analysis. In 2024, PMA review times averaged 363.2 days—down from 760.8 days in 2023.

FDA Approved vs. FDA Cleared vs. FDA Granted vs. FDA Registered

One of the most dangerous consumer misconceptions is treating these terms as interchangeable. They are not. Each represents a fundamentally different level of FDA scrutiny.

The 510(k) “Cleared” Problem

Most medical devices reach the market through the 510(k) clearance pathway, not through FDA approval. Under this process, manufacturers must only demonstrate their device is “substantially equivalent” to a product already on the market—called a predicate device.

The FDA does not conduct its own testing. It relies on test results from manufacturers and independent labs. This creates a significant loophole: companies can sometimes use recalled products as predicates.

From 2018 to 2022, there were 189 unique Class I medical device recalls—the most serious type. From 1992 to 2012, devices cleared through 510(k) were 11.5 times more likely to be recalled than PMA-approved devices.

Products the FDA Does NOT Approve

Many consumers assume that if a product sits on store shelves, the FDA has approved it. This assumption is false for several major product categories.

Dietary Supplements

Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplements are regulated as food, not drugs. The FDA does not review or approve dietary supplements based on their safety and effectiveness before they reach consumers.

Manufacturers can sell supplements without proving they work. The FDA can only take action after a product causes harm. In August 2021, the FDA recalled 72 weight loss supplements after discovering hidden drugs—including sibutramine (sold as Meridia), which had been withdrawn from the market for causing heart attacks.

Research has found that some herbal medications contain high concentrations of lead, mercury, and arsenic. In one study of 247 traditional Chinese medicines, 5-15% contained arsenic, 5% contained lead, and 65% contained mercury.

Cosmetics

Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), FDA authority over cosmetics expanded—but cosmetics still do not need FDA premarket approval, with the exception of color additives. The FDA can pursue enforcement only after products reach the market and violate the law.

Homeopathic Products

There are currently no homeopathic drug products approved by the FDA. The FDA considers all homeopathic drugs to be unapproved “new drugs” that could technically be removed from the market at any time.

CBD Products

The FDA has approved only one CBD-based prescription drug: Epidiolex. All other CBD products sold in foods, beverages, or as dietary supplements operate in a regulatory gray area. The FDA regularly issues warning letters to companies making unauthorized health claims.

Pet Food

Pet food is regulated by the FDA, but the agency does not approve individual pet food products. Critics note that the FDA’s Center for Veterinary Medicine has stated it does not believe diseased animals in pet food pose a safety concern—a position many pet owners find troubling.

Bottled Water

The FDA regulates bottled water as a packaged food product but does not approve bottled water firms or products. Standards must be at least as stringent as EPA tap water standards, but there is no pre-market approval process.

E-Cigarettes and Vapes

Only 39 e-cigarette products from four manufacturers have FDA marketing authorization as of 2025. The FDA has stated that 54% of vape products currently sold are unauthorized and illegal.

Real Examples: FDA-Approved Products That Caused Harm

FDA approval does not guarantee permanent safety. The following products received FDA approval or clearance, then were recalled or withdrawn after causing serious harm.

Vioxx (Rofecoxib) – Prescription Drug

Time on market: 1999-2004

Merck voluntarily withdrew Vioxx on September 30, 2004 after clinical trials showed increased risk of heart attack and stroke. The drug was linked to approximately 27,785 heart attacks or sudden cardiac deaths between 1999 and 2003. Vioxx had been prescribed to more than 20 million people and was advertised by Olympic gold medalists Dorothy Hamill and Bruce Jenner.

Bextra (Valdecoxib) – Prescription Drug

Time on market: 2001-2005

The FDA asked Pfizer to voluntarily remove Bextra on April 7, 2005. The drug caused serious cardiovascular events including death, heart attack, and stroke, plus serious skin reactions. The FDA determined Bextra showed no advantage over other NSAIDs. The manufacturer paid $2 billion in damages plus a $1.19 billion fine for criminal wrongdoing.

Zantac (Ranitidine) – OTC Drug

Time on market: Decades (recalled April 2020)

The FDA requested immediate withdrawal of all ranitidine products on April 1, 2020 after discovering unacceptable levels of NDMA, a probable carcinogen. Unlike other contamination cases, NDMA was created by a reaction within the drug itself, especially when stored at temperatures higher than room temperature.

DePuy ASR Hip Implant – Medical Device (510(k) Cleared)

Time on market: 2005-2010

DePuy obtained FDA clearance through the 510(k) pathway—the loophole that allowed marketing with minimal testing. The ASR hip implant had high failure rates, causing metallosis, inflammation, infection, and need for revision surgery. Johnson & Johnson settled approximately 8,000 claims for about $4 billion.

Philips CPAP Machines – Medical Device

Recall date: June 2021

Philips recalled 15 million CPAP, BiPAP, and ventilator devices worldwide because foam used to reduce sound could break down and be breathed in by users. The FDA received more than 116,000 medical device reports associated with recalled devices. A 2023 investigation revealed Philips had evidence of the foam problem more than a decade before the recall. In April 2024, a federal consent decree required Philips to stop selling most sleep devices in the U.S.

Essure – Medical Device (PMA Approved)

Time on market: 2002-2018

Bayer’s Essure permanent birth control device received PMA approval—the most rigorous pathway. Yet the FDA received more than 17,000 medical device reports in 2017-2018 alone. Problems included persistent pain, perforation of the uterus and fallopian tubes, and migration of the coils. Bayer faced lawsuits from approximately 16,000 U.S. women and stopped selling Essure in December 2018.

Aduhelm (Aducanumab) – Prescription Drug (Accelerated Approval)

Time on market: 2021-2024

The FDA approved Aduhelm for Alzheimer’s disease in June 2021 despite its advisory committee voting 10-0 against approval. Three advisory committee members resigned in protest. The drug’s high cost and questionable efficacy meant physicians hesitated to prescribe it and insurers refused to pay. Biogen pulled Aduhelm from the market in January 2024.

The Accelerated Approval Controversy

The FDA’s Accelerated Approval Program allows earlier approval for drugs treating serious conditions with unmet medical needs. However, critics point to serious problems:

• Post-approval confirmatory trials are often delayed—sometimes taking more than a decade
• Some drugs have been proven ineffective or unsafe after years on the market
• Over 64% of drugs approved between 2015-2017 used expedited pathways—up from 35% twenty years earlier

A January 2025 report from the HHS Office of Inspector General identified concerns with three accelerated approvals out of 24 reviewed, including Aduhelm.

FDA Approval and Your Right to Sue

A critical question for injured consumers: Does FDA approval protect manufacturers from lawsuits? The answer depends on the product type.

Medical Devices: The Riegel Preemption

In Riegel v. Medtronic (2008), the Supreme Court held that state product liability claims are preempted (blocked) when a medical device received PMA approval. The Court reasoned that allowing lawsuits would second-guess FDA’s safety judgment.

However, in Medtronic v. Lohr (1997), the Court found that 510(k) clearance does not preempt lawsuits because the 510(k) process focuses on equivalence, not safety.

Prescription Drugs: No Automatic Preemption

In Wyeth v. Levine (2009), the Supreme Court ruled 6-3 that FDA approval of drug warning labels does not bar state law tort claims. The Court noted that Congress never expressly foreclosed state law claims against drug manufacturers—unlike with medical devices.

However, in 2025, a federal court granted summary judgment to Merck in Gardasil vaccine litigation based on labeling preemption, dismissing hundreds of cases. The preemption analysis remains complex and fact-specific.

Mistakes to Avoid

Mistake 1: Assuming “FDA Regulated” Means “FDA Approved”

Many products (cosmetics, supplements, pet food) are FDA regulated but not FDA approved. Regulation means the FDA can take enforcement action after problems arise—not that the FDA reviewed the product before sale.

Mistake 2: Trusting “FDA Registered” Claims

When a company says it is “FDA registered,” this only means they paid a fee and listed their establishment with the FDA. It implies no safety review whatsoever.

Mistake 3: Believing Supplements Are Pre-Tested

Under DSHEA, manufacturers do not need to prove safety or efficacy before selling supplements. You cannot assume supplements have been tested for what they claim.

Mistake 4: Assuming Recalled Products Were Never “Approved”

Many recalled products—including Vioxx, Bextra, and Essure—did receive FDA approval or clearance. Approval is based on data available at the time. New safety issues can emerge years later.

Mistake 5: Thinking FDA Approval Blocks Your Lawsuit

For drugs and 510(k)-cleared devices, FDA approval does not automatically protect manufacturers from product liability lawsuits. Consult an attorney to understand your rights.

Do’s and Don’ts

Do’s

✅ Verify the FDA designation. Check the FDA’s official databases to confirm whether a product is approved, cleared, granted, or simply registered.

✅ Report adverse events. Use MedWatch to report problems with drugs, devices, cosmetics, or supplements. FDA relies on post-market reports to identify safety issues.

✅ Research supplement brands. Look for third-party certifications (USP, NSF, ConsumerLab) since the FDA does not pre-test supplements.

✅ Check recall databases. Visit FDA’s recall page regularly, especially if you use medical devices.

✅ Consult attorneys about injuries. Even FDA-approved products may not be protected from lawsuits, depending on the product type and circumstances.

Don’ts

❌ Don’t assume “natural” means safe. Herbal supplements can contain heavy metals and hidden drugs.

❌ Don’t rely on product marketing. Companies sometimes use misleading terms like “FDA registered” to imply safety review that never occurred.

❌ Don’t ignore side effects. If you experience problems after using any product, document them and report to your healthcare provider and the FDA.

❌ Don’t assume old products are safe. Products on the market for decades (like Zantac) can be recalled when new evidence emerges.

❌ Don’t wait to see a doctor. If you’re injured by a product, seek medical care first—then consider your legal options.

Pros and Cons of FDA Approval

Pros of FDA Approval

✅ Evidence-based review. FDA approval requires clinical trial data demonstrating benefits outweigh risks—more rigorous than self-certification.

✅ Post-market surveillance. The FDA monitors adverse event reports and can require additional studies or issue recalls.

✅ Labeling requirements. Approved products must include accurate warnings and usage instructions.

✅ Manufacturing standards. Manufacturers must follow Current Good Manufacturing Practices (cGMP).

✅ International credibility. FDA approval is often recognized or influential globally, facilitating international access to therapies.

Cons of FDA Approval

❌ Not a guarantee of safety. Approved products are later recalled when problems emerge after widespread use.

❌ Limited post-market enforcement. The FDA has limited resources and cannot monitor all products continuously.

❌ Approval based on available data. Clinical trials cannot identify rare side effects or long-term problems that only appear after years of use.

❌ 510(k) loophole undermines device safety. Most devices reach market through a pathway focused on equivalence, not safety testing.

❌ May limit legal recourse. For PMA-approved devices, preemption can block product liability lawsuits.

Three Common Scenarios

Scenario 1: Maria Buys “FDA Registered” Supplements

Maria wants to lose weight and finds supplements marketed as “FDA registered” at her local store. She assumes this means the FDA has tested them for safety and efficacy.

Outcome: Maria experiences heart palpitations. She later learns the supplement contained undisclosed stimulants. She reports to MedWatch and consults an attorney about potential claims.

Scenario 2: James Receives a 510(k)-Cleared Hip Implant

James needs hip replacement surgery. His surgeon recommends a device that received 510(k) clearance. James assumes this means FDA conducted safety testing.

Outcome: James’s implant fails after three years, requiring revision surgery. He successfully sues the manufacturer because 510(k)-cleared devices are not protected by preemption.

Scenario 3: Sarah Uses an FDA-Approved Prescription Drug

Sarah takes an FDA-approved medication for arthritis. Five years later, she suffers a heart attack linked to the drug.

Outcome: Sarah consults a product liability attorney and joins a mass tort action against the manufacturer. Under Wyeth v. Levine, FDA approval does not automatically protect drug companies from lawsuits.

Key Entities and Their Roles

Center for Drug Evaluation and Research (CDER): Reviews and approves new drugs. In 2024, CDER approved 50 novel drugs.

Center for Devices and Radiological Health (CDRH): Oversees medical device approvals, clearances, and recalls. Issued 47 warning letters in fiscal year 2024—a 96% increase from 2023.

Center for Biologics Evaluation and Research (CBER): Regulates vaccines, blood products, and gene therapies.

Center for Food Safety and Applied Nutrition (CFSAN): Oversees food safety, cosmetics, and dietary supplements.

Center for Tobacco Products (CTP): Regulates tobacco and e-cigarette products. Only 39 e-cigarette products are currently authorized.

2024-2025 Drug Recalls

Recent recalls demonstrate that FDA-approved products continue to face safety issues:

In fiscal year 2024, the FDA issued 190 inspection-based warning letters—more than double the 94 issued in 2023.

FAQs

Does FDA approval guarantee a product is safe?
No. FDA approval means benefits outweigh known risks at approval time. Products can be recalled later when new problems emerge.

Can I sue a company if their FDA-approved product injures me?
Yes, in most cases. For drugs and 510(k)-cleared devices, FDA approval does not automatically block lawsuits under Wyeth v. Levine and Medtronic v. Lohr.

Are dietary supplements FDA approved?
No. Supplements are regulated as food, not drugs. The FDA does not review them before sale and can only act after harm occurs.

Does “FDA registered” mean a product was safety-tested?
No. Registration only means a company paid fees and listed products. It implies no safety review whatsoever.

Are cosmetics FDA approved before they’re sold?
No. Cosmetics do not need premarket approval, except for color additives. The FDA can only take action after violations occur.

What’s the difference between FDA approved and FDA cleared?
Approved requires clinical trial data proving benefits outweigh risks. Cleared only requires showing a device is similar to one already on the market.

Can I sue if a PMA-approved medical device injures me?
Generally no. Under Riegel v. Medtronic, state law claims against PMA-approved devices are typically preempted by federal law.

Are all e-cigarettes FDA authorized?
No. Only 39 e-cigarette products from four manufacturers have FDA authorization. The FDA estimates 54% of products sold are unauthorized.

Is pet food FDA approved?
No. The FDA regulates pet food but does not approve individual products. Manufacturers are responsible for safety before FDA takes action.

Does FDA approval mean a drug will never be recalled?
No. Approximately 35 drugs have been recalled from the U.S. market since the 1970s—many after causing thousands of injuries.

How long does FDA drug approval take?
Varies. The full process, including clinical trials, typically takes 10-15 years. FDA review alone averages 10-12 months for standard review.

Are homeopathic products FDA approved?
No. The FDA considers all homeopathic products unapproved new drugs. They remain on the market through enforcement discretion.